Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$655M |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$383M |
| 3 |
Coca-Cola
KO
|
+$367M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$347M |
| 5 |
Salesforce
CRM
|
+$328M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Spotify
SPOT
|
+$314M |
| 2 |
CME Group
CME
|
+$263M |
| 3 |
Adobe
ADBE
|
+$232M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$220M |
| 5 |
Northrop Grumman
NOC
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.32% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Financials | 8.41% |
| 4 | Industrials | 8.19% |
| 5 | Healthcare | 4.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MPT
2601
CALL
Medical Properties Trust
MPT
$2.46B
| $75.8K | ﹤0.01% |
19,200
| – | – |
|
2602
Titan International
TWI
$454M
| $73.9K | ﹤0.01% |
+10,886
| New | +$78.4K |
|
2603
Stem
STEM
$52.6M
| $73.2K | ﹤0.01% |
6,069
+5,163
| +570% | +$44.5K |
|
|
RVNC
2604
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $71.4K | ﹤0.01% |
23,500
-100,000
| -81% | -$436K |
|
2605
Butterfly Network
BFLY
$2.38B
| $71.2K | ﹤0.01% |
+22,825
| New | +$59.4K |
|
2606
CALL
NIO
NIO
$10.9B
| $65.4K | ﹤0.01% |
+15,000
| New | +$76.3K |
|
|
CKPT
2607
DELISTED
Checkpoint Therapeutics
CKPT
| $64.7K | ﹤0.01% |
+20,221
| New | +$68.6K |
|
|
SRTA
2608
Strata Critical Medical Inc
SRTA
$528M
| $62K | ﹤0.01% |
+14,600
| New | +$55.6K |
|
2609
Babcock & Wilcox
BW
$1.15B
| $60.2K | ﹤0.01% |
+36,711
| New | +$77.6K |
|
2610
Xeris Biopharma Holdings
XERS
$1.59B
| $58.1K | ﹤0.01% |
+17,153
| New | +$55.2K |
|
|
URG
2611
Ur-Energy
URG
$569M
| $57.1K | ﹤0.01% |
+49,651
| New | +$61.3K |
|
2612
Aldeyra Therapeutics
ALDX
$91.7M
| $56.3K | ﹤0.01% |
+11,278
| New | +$57.9K |
|
2613
Hertz
HTZ
$781M
| $55.2K | ﹤0.01% |
+15,080
| New | +$54.5K |
|
2614
LifeMD
LFMD
$151M
| $51.6K | ﹤0.01% |
+10,423
| New | +$54.6K |
|
2615
Gray Television
GTN
$507M
| $51.2K | ﹤0.01% |
16,243
-21,006
| -56% | -$98.1K |
|
2616
Bit Digital
BTBT
$545M
| $50.4K | ﹤0.01% |
+17,201
| New | +$67.6K |
|
2617
EVgo
EVGO
$210M
| $48.6K | ﹤0.01% |
11,996
-247,492
| -95% | -$1.57M |
|
|
LFT
2618
Lument Finance Trust
LFT
$35.3M
| $48.5K | ﹤0.01% |
+18,801
| New | +$48.2K |
|
2619
Prime Medicine
PRME
$589M
| $47.7K | ﹤0.01% |
+16,342
| New | +$57.4K |
|
2620
Lloyds Banking Group
LYG
$87.6B
| $46K | ﹤0.01% |
16,904
-7,847
| -32% | -$22.4K |
|
2621
Blend Labs
BLND
$355M
| $45.9K | ﹤0.01% |
+10,905
| New | +$46.9K |
|
2622
Ambev
ABEV
$45B
| $42.9K | ﹤0.01% |
23,207
-37,862
| -62% | -$83.8K |
|
2623
AbCellera Biologics
ABCL
$3.44B
| $39.6K | ﹤0.01% |
+13,521
| New | +$37.7K |
|
2624
Quantum-Si Incorporated
QSI
$168M
| $36.4K | ﹤0.01% |
+13,488
| New | +$15.8K |
|
2625
Rackspace Technology
RXT
$795M
| $36.1K | ﹤0.01% |
+16,355
| New | +$41.3K |
|
Similar funds
Dmitry Balyasny's Q4 2024 Portfolio in Review
As of Q4 2024, Dmitry Balyasny held 3,413 positions worth $67.1B, up 9.5% from $61.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny deployed $4.68B of net new capital in Q4 2024, opening 750 new positions and adding to 913 existing holdings. Its largest new stake was Cisco: 4,075,610 shares worth $241M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.4% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Spotify, an estimated $314M trimmed.
- Dmitry Balyasny's largest Q4 2024 buy was Cisco: 4,075,610 shares worth $241M.
- Dmitry Balyasny added most to Amazon in Q4 2024, an estimated $655M increase.
- Dmitry Balyasny's biggest Q4 2024 reduction was Spotify, cutting an estimated $314M.
- Dmitry Balyasny fully exited CATALENT, INC. in Q4 2024, selling an estimated $220M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $67.1B portfolio in Q4 2024.
- Dmitry Balyasny opened 750 new positions and closed 747 in Q4 2024.
- Dmitry Balyasny's portfolio value rose 9.5% quarter-over-quarter to $67.1B.
Based on Balyasny Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.